A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies

Molybdenum Cofactor Deficiency Clinical Trial

Official title:
A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies

Status Completed

Clinical Trial Summary

Primary objective:

Characterize the natural history of MoCD type A in terms of survival

Secondary objectives:

1. Evaluate blood and urine for biochemical markers

2. Evaluate head circumference, seizure activity and neurologic outcomes

3. To evaluate brain MRI

4. Compare blood and urine analysis, head circumference, seizure activity and neurologic outcomes to MRI findings

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Amino Acid Metabolism, Inborn Errors
Isolated Sulfite Oxidase Deficiency
Molybdenum Cofactor Deficiency

Clinical Trial Details

NCT number	NCT01735188
Study type	Observational
Source	Origin Biosciences
Contact
Status	Completed
Phase
Start date	August 2013
Completion date	June 2016

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01640717` - A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)